Merck Serono tweaks Swiss restructuring plans
June 20, 2012Manufacturing and Production, Sales and Marketing Merck Serono, cuts, restructuring
Merck KGaA has finalised the restructuring plans at Swiss drugs unit Merck Serono, confirming that it intends to close its …
Analysts want AstraZeneca-AbbVie tie-up
June 20, 2012Sales and Marketing AbbVie, Abbott, AstraZeneca, merger
Analysts want Abbott’s new spin-off firm AbbVie to merge with the troubled AstraZeneca, saying it could give both firms future …
EMA clarifies antibodies development
June 20, 2012Manufacturing and Production, Research and Development, Sales and Marketing CMPHU, EMA, RA, antibodies
European regulators have issued final guidance on how pharma manufacturers should develop drugs containing monoclonal antibodies. Typically used in treatments …
Life appoints new digital director
June 20, 2012Business Services, Medical Communications, Sales and Marketing Life, digital director
Life Healthcare Communications has appointed a new digital director to head up its expanding digital department. Francesco Raimo joins Life …
Merck KGaA confirms leadership team appointments
June 20, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMD Serono, Merck KGaA, Serono
The subsidiary of Merck KGaA named EMD Serono has announced several appointments to its leadership team. The appointments include: Allene …
Storm clouds gathering over the NHS, say its leaders
June 20, 2012Sales and Marketing Mike Farrar, NHS Confederation, NHS reforms, reforms
NHS managers are using their annual conference to criticise the government’s savings programmes. The government is looking to make £20 …
Xbox Kinect technology to help stroke victims
June 19, 2012Medical Communications Gamification, Roke, Southampton, Xbox, stroke
The University of Southampton and Roke Manor Research have pioneered the use of Microsoft’s Xbox technology to help stroke patients …
Roche signs research deal on autism spectrum disorders
June 19, 2012Research and Development, Sales and Marketing ASD, FXS, Roche, Seaside Therapeutics, asperger's, autism
Roche has signed an agreement with Seaside Therapeutics to develop new treatments for autism and other neurodevelopmental conditions such as …
Senates and networks – do they have a role in the new NHS?
June 19, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, health forum, reforms, senates and networks
The recent Westminster Health Forum meeting on ‘Developing Clinical Senates and Networks’ focused on one aspect of the new NHS …
Cmed Clinical Services showcases new in-house drug development consulting, regulatory and Medical Affairs group at DIA 2012
June 19, 2012Research and Development
HORSHAM, UK — June 18, 2012 – Cmed Clinical Services, the global CRO specialised in the design and delivery of …
Akzo Nobel’s Mexican API plant all clear
June 19, 2012Manufacturing and Production API, Akzo Nobel, FDA, manufacturing
Akzo Nobel has brought a manufacturing facility for active pharmaceutical ingredients in Mexico that failed an inspection last year back …
Patheon hikes revenue guidance for 2012
June 19, 2012Manufacturing and Production CDMO, Canadian, PDS, Patheon
Canadian contract development and manufacturing organisation (CDMO) Patheon reported a solid set of financial figures for the second quarter of …
Pharma manufacturing news in brief
June 19, 2012Manufacturing and Production BioWa, Cytovance Biologics, DHL, Dalton Pharma Services, Lonza, Particle Sciences, Recipharm
DHL opens up a facility in Mumbai, Recipharm invests in French filling plant, plus updates from Dalton Pharma Services, Particle …
FDA holds up Pfizer’s rare disease drug tafamidis
June 19, 2012Research and Development, Sales and Marketing FDA, Pfizer, rare disease, tafamidis
The FDA has sent Pfizer a Complete Response Letter about its rare disease drug tafamidis meglumine. The US regulator is …
GSK partners with Cambridge University
June 18, 2012Research and Development, Sales and Marketing ABPI, Cambridge, GSK, R&D
The University of Cambridge begins a new collaboration with GlaxoSmithKline today to advance drug discovery and the development of new …
PMCPA reprimands Chiesi for multiple breaches
June 18, 2012Sales and Marketing COPD, Chiesi, GSK, PMCPA, code
Chiesi has been publicly reprimanded by the PMCPA part for promoting its asthma drug Fostair off-label. The embarrassing slapdown from …
Pfizer launches ‘Campaign Against Migraine’ website
June 18, 2012Medical Communications Botox, Pfizer, Relpax, digital, migraine
Pfizer has launched a new website called ‘Campaign Against Migraine’ to help migraine sufferers in the US learn more about …
New director appointments to the NHS Commissioning Board
June 18, 2012Medical Communications, Sales and Marketing Lansley, NHS, reforms
Lord Adebowale, Margaret Casely-Hayford, Dame Moira Gibb and Naguib Kheraj have been confirmed as four new non-executive directors of the …
Janssen looks to broaden Zytiga licence
June 18, 2012Sales and Marketing Cancer, Janssen, NICE, Provenge, Zytiga, prostate
Janssen is looking to broaden the licence for its prostate cancer pill Zytiga. Zytiga currently has a US and European …
New director of market access at Celgene UK and Ireland
June 18, 2012Business Services, Medical Communications, Sales and Marketing Celgene, Nicola Redfern, oncology
Celgene has announced the appointment of Nicola Redfern as director of market access, Celgene UK and Ireland. Redfern brings a …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
